These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
216 related articles for article (PubMed ID: 16480596)
1. [Clinical significance of serum GPDA-F determined by immunoelectrophoresis in diagnosis of hepatocellular carcinoma]. Liu HD; Ni RZ; Xiao MB; Li LR; Hua GP; Kuai XL Ai Zheng; 2006 Feb; 25(2):247-9. PubMed ID: 16480596 [TBL] [Abstract][Full Text] [Related]
2. [The value of serum GPDA-F for the diagnosis of primary hepatocellular carcinoma]. Li M; Ni R; Huang J; Xiao M; Zhang H; Wei Q; Jiang F; Meng X Zhonghua Gan Zang Bing Za Zhi; 2000 Jun; 8(3):139-41. PubMed ID: 10880158 [TBL] [Abstract][Full Text] [Related]
3. Glycylproline dipeptidyl aminopeptidase isoenzyme in diagnosis of primary hepatocellular carcinoma. Ni RZ; Huang JF; Xiao MB; Li M; Meng XY World J Gastroenterol; 2003 Apr; 9(4):710-3. PubMed ID: 12679916 [TBL] [Abstract][Full Text] [Related]
4. [Detection of GGT-II by dot-ELISA with monoclonal antibody in the diagnosis of hepatocellular carcinoma]. Ni RZ; Huang JF; Xiao MB; Zhang PY; Meng XY Ai Zheng; 2004 Jan; 23(1):66-8. PubMed ID: 14720378 [TBL] [Abstract][Full Text] [Related]
5. [Subject diagnostic value of detecting a1pha-fetoprotein variants with a new microspincolumn method in hepatocellular carcinoma]. Xu AF; Wang MC; Sui DM; Yuan YH; Chen G; Lou GQ Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2007 Mar; 21(1):67-9. PubMed ID: 17429541 [TBL] [Abstract][Full Text] [Related]
6. 5'-Nucleotide phosphodiesterase isozyme-V in hepatocellular carcinoma and other liver diseases. Fujiyama S; Tsude K; Sakai M; Sato T Hepatogastroenterology; 1990 Oct; 37(5):469-73. PubMed ID: 1701410 [TBL] [Abstract][Full Text] [Related]
7. [Detection of alpha-fetoprotein-L3 using agglutinin-coupled spin column to be used in diagnosis of hepatocellular carcinoma]. Sun GZ; Zhao XY; Li JH; Zhao GQ; Wang SX; Kong SL Zhonghua Yi Xue Za Zhi; 2008 Jul; 88(28):1986-8. PubMed ID: 19062741 [TBL] [Abstract][Full Text] [Related]
8. Prognostic significance of three hepatitis markers (p53 antibodies, vascular endothelial growth factors and alpha fetoprotein) in patients with hepatocellular carcinoma. Gadelhak NA; Gadelhak SA; El-Morsi DA; Abdelaziz MM; Abbas AT; El-Emshaty HM Hepatogastroenterology; 2009; 56(94-95):1417-24. PubMed ID: 19950803 [TBL] [Abstract][Full Text] [Related]
9. Combined serum hepatoma-specific alpha-fetoprotein and circulating alpha-fetoprotein-mRNA in diagnosis of hepatocellular carcinoma. Wu W; Yao DF; Yuan YM; Fan JW; Lu XF; Li XH; Qiu LW; Zong L; Wu XH Hepatobiliary Pancreat Dis Int; 2006 Nov; 5(4):538-44. PubMed ID: 17085339 [TBL] [Abstract][Full Text] [Related]
10. [Clinical research of AFP variant with microcentrifugalcolumn method and crossed affinity immunoelectrophoresis autoradiography method]. Chen Y; Lin YY; Hu MH; Chen YS Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2008 Oct; 22(5):379-81. PubMed ID: 19469181 [TBL] [Abstract][Full Text] [Related]
11. [Serum arginase activity in patients with liver cirrhosis and hepatocellular carcinoma]. Chrzanowska A; Mielczarek-Puta M; Skwarek A; Krawczyk M; Barańczyk-Kuźma A Wiad Lek; 2007; 60(5-6):215-8. PubMed ID: 17966882 [TBL] [Abstract][Full Text] [Related]
12. [Clinical significance of AFP-L3 variants determined by micro centrifugal column]. Wang YZ; Luo LB; Wu GX; Chen M; Ruan LH; Pu XK; Hang SR Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2007 Jun; 21(2):135-7. PubMed ID: 17653315 [TBL] [Abstract][Full Text] [Related]
13. Des-gamma-carboxyprothrombin, alpha-fetoprotein and AFP-L3 in patients with chronic hepatitis, cirrhosis and hepatocellular carcinoma. Durazo FA; Blatt LM; Corey WG; Lin JH; Han S; Saab S; Busuttil RW; Tong MJ J Gastroenterol Hepatol; 2008 Oct; 23(10):1541-8. PubMed ID: 18422961 [TBL] [Abstract][Full Text] [Related]
14. Aldolase A isoenzyme levels in serum and tissues of patients with liver diseases. Asaka M; Nagase K; Miyazaki T; Alpert E Gastroenterology; 1983 Jan; 84(1):155-60. PubMed ID: 6183164 [TBL] [Abstract][Full Text] [Related]
15. [Significance of Golgi glycoprotein 73, a new tumor marker in diagnosis of hepatocellular carcinoma: a primary study]. Mao YL; Yang HY; Xu HF; Sang XT; Lu X; Yang ZY; Zhang JC; Zhong SX; Huang JF; Zhang HB Zhonghua Yi Xue Za Zhi; 2008 Apr; 88(14):948-51. PubMed ID: 18756964 [TBL] [Abstract][Full Text] [Related]
16. Study of serum haptoglobin and its glycoforms in the diagnosis of hepatocellular carcinoma: a glycoproteomic approach. Ang IL; Poon TC; Lai PB; Chan AT; Ngai SM; Hui AY; Johnson PJ; Sung JJ J Proteome Res; 2006 Oct; 5(10):2691-700. PubMed ID: 17022640 [TBL] [Abstract][Full Text] [Related]
17. Surface enhanced laser desorption/ionization profiling: New diagnostic method of HBV-related hepatocellular carcinoma. Wu C; Wang Z; Liu L; Zhao P; Wang W; Yao D; Shi B; Lu J; Liao P; Yang Y; Zhu L J Gastroenterol Hepatol; 2009 Jan; 24(1):55-62. PubMed ID: 18823443 [TBL] [Abstract][Full Text] [Related]
18. Rapid kinetic rate assay of the serum alpha-L-fucosidase in patients with hepatocellular carcinoma by using a novel substrate. Wang JJ; Cao EH Clin Chim Acta; 2004 Sep; 347(1-2):103-9. PubMed ID: 15313147 [TBL] [Abstract][Full Text] [Related]
19. [Optimal cut-off value of PIVKA-II for diagnosis of hepatocellular carcinoma--using ROC curve]. Kim MJ; Bae KW; Seo PJ; Jeong IK; Kim JH; Lee BH; Bang KT; Kim DW; Song IH Korean J Hepatol; 2006 Sep; 12(3):404-11. PubMed ID: 16998292 [TBL] [Abstract][Full Text] [Related]
20. The clinical significance of serum alpha-L-fucosidase assay in hepatocellular carcinoma. Yamamoto K; Yanagita T; Watanabe N; Morito F; Ozaki I; Motomura M; Ikuyama S; Setoguchi Y; Fujii S; Kariya T Fukuoka Igaku Zasshi; 1988 Jun; 79(6):463-8. PubMed ID: 2852632 [No Abstract] [Full Text] [Related] [Next] [New Search]